J2K Bio Posts Q1 Operating Profit of 1.91 Billion Won, Up 476% Year-on-Year

J2K Bio announced on May 14 that its consolidated operating profit for the first quarter of this year reached 1.91 billion won, a 476% increase compared to the same period last year. During the same period, sales amounted to 11.1 billion won, growing by 53.1% year-on-year, while net profit was recorded at 1.59 billion won.

The growth in first-quarter performance was driven by increased sales from both existing and new clients. Sales to major domestic ODM (Original Development Manufacturing) partners rose, and sales to brand clients, which had previously been sluggish, also showed signs of recovery. Additionally, OEM (Original Equipment Manufacturing) sales to newly acquired domestic beauty brands contributed to the overall expansion in scale.

J2K Bio is strengthening its product portfolio by focusing on high value-added raw materials such as PDRN and peptides. As demand for functional and high-efficacy ingredients increases in the global cosmetics market, the company’s competitiveness in raw material supply is being recognized as a key driver of its performance growth.

The recovery in demand for K-beauty has also played a positive role. Since the second half of last year, the overseas expansion of domestic cosmetics brands has accelerated, benefitting raw material suppliers. J2K Bio is maintaining its growth trend by diversifying its client base and increasing supply volumes.

J2K Bio expects its sales growth to continue into the second quarter. While the boom among cosmetics ODM and brand companies persists, the company anticipates that expanded supply to major clients and increased sales at clinical centers will serve as additional growth drivers.

A J2K Bio representative stated, "In the first quarter, we simultaneously achieved growth in scale and improved profitability through expanded sales to existing clients, acquisition of new clients, and improvements in our clinical center business," adding, "With continued growth in the K-beauty industry and increasing demand for functional and high-efficacy ingredients, we expect to sustain stable growth into the second quarter as well."

This content was produced with the assistance of AI translation services.